NorthCoast Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$987K Buy
+2,645
New +$1.01M 0.04% 268
2020
Q4
Sell
-6,941
Closed -$1.87M 387
2020
Q3
$1.87M Buy
6,941
+1,710
+33% +$460K 0.09% 128
2020
Q2
$1.38M Sell
5,231
-322
-6% -$85.9K 0.08% 144
2020
Q1
$1.26M Buy
+5,553
New +$1.51M 0.08% 137
2019
Q2
Sell
-2,578
Closed -$740K 264
2019
Q1
$740K Buy
+2,578
New +$746K 0.05% 173
2014
Q1
Sell
-11,454
Closed -$1.06M 176
2013
Q4
$1.06M Hold
11,454
0.07% 111
2013
Q3
$958K Buy
+11,454
New +$982K 0.07% 111

Other funds holding ELV

NorthCoast Asset Management's ELV Position: Q3 2021 in Review

NorthCoast Asset Management opened a new position in Elevance Health (ELV) in Q3 2021: 2,645 shares worth $987K. The stake represents 0.04% of the portfolio and ranks #268 among its holdings. This is a return to the name: NorthCoast Asset Management previously reported a position in ELV as recently as Q3 2020.

NorthCoast Asset Management first reported a position in ELV in Q3 2013 and has held it in 7 quarters since. The position peaked at $1.87M in Q3 2020. 1,215 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • NorthCoast Asset Management held 2,645 shares of Elevance Health worth $987K as of Q3 2021.
  • Elevance Health was a new NorthCoast Asset Management position in Q3 2021.
  • Elevance Health made up 0.04% of NorthCoast Asset Management's portfolio in Q3 2021, its #268 holding.
  • NorthCoast Asset Management first reported a position in Elevance Health in Q3 2013 and has held it in 7 quarters since.
  • NorthCoast Asset Management's Elevance Health position peaked at $1.87M in Q3 2020.
  • 1,215 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on NorthCoast Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.